DHR News and Press, Danaher Corporation

Danaher Releases 2024 Sustainability Report PR Newswire WASHINGTON , July 16, 2024 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher" or the "Company"), the global life sciences and diagnostics innovator, today published its 2024 Sustainability Report whi...

2024-07-16 05:03:36 ET Summary The valuation is historically high, while sales are falling year-on-year. Danaher is issuing worse forecasts for 2024 than analysts estimate. Overall, I think the negative aspects outweigh the positive ones, at least in the short to medium time h...

2024-07-16 04:20:00 ET Summary The Akre Focus Fund’s Q2 2024 performance (Inst.) was -1.86% vs. S&P 500 Total Return at 4.28%. The Fund owns businesses that are neither the largest nor most popular, and looking forward we see this as a plus. The top-5 contributors t...

2024-07-12 14:30:06 ET More on Exact Sciences: Exact Sciences: Still No Reason To Own Exact Sciences Corporation (EXAS) Q1 2024 Earnings Call Transcript Exact Sciences initiated at sector outperform at Scotiabank on advanced diagnostics Exact Sciences gains a...

2024-07-11 07:55:00 ET Summary In this quarterly report, we have outlined our assessment of the current investment environment and the implications of very ‘narrow’ equity markets, where a few companies are driving index returns. We do a review of the last quarter, i...

Danaher Launches Beacon Research Collaboration with Stanford University Aiming to Build Next Generation of Smart Microscopes for Cancer Drug Screening PR Newswire Predictive tools will seek to reduce leading cause of failure rates in clinical trials of oncology drugs. ...

Beckman Coulter Introduces New Integrated Chemistry and Immunoassay Analyzer PR Newswire Ideally Suited for Satellite and Independent Labs, the new DxC 500i Analyzer Offers Flexibility, Scalability and Data Commutability with Extensive Chemistry and Immunoassay Assay Menu ...

2024-07-07 09:00:00 ET Summary BlackRock Health Sciences Trust is a healthcare sector-specific closed-end fund that invests in a fairly diversified portfolio of common stocks in the healthcare sector. It currently provides a reasonable yield of 6.3% plus an attractive discount of ...

2024-07-03 11:58:05 ET Summary Revvity, Inc., formerly PerkinElmer, has struggled post-pandemic due to poor capital allocation decisions, leading to stagnant growth and disappointing financial performance. With 2024 set up to become another lost year, in terms of growth, it is cle...

2024-07-03 06:19:10 ET Summary Healthcare capex demand has supported healthy order growth at Siemens Healthineers, as the company leverages new innovative platforms in Imaging (MRI, CT) and radiation oncology (Varian). The Street wants margin leverage and order growth in FQ3'24, a...